Shandong Jincheng Pharmaceutical Group Co., Ltd.
Build a characteristic pharmaceutical industry chain
Becoming an innovative leading enterprise in the pharmaceutical and health industry
Achievement
20 Years
Since 2004
USD 500+ Million
Fiscal Year Revenue in 2022
32
Participating Holding Companies
10+
Production Base
An Important Part of Jincheng Pharma Group
— Synthetic Biology
“We partner with nature to make better products, in a better way, for a better world.”
标题
Make Your Marks in JINCHENG PHARMA

JINCHENG PHARMA's Partners

About Jincheng Pharma
Shandong Jincheng Pharmaceutical Group Co., Ltd. was established in 2004 and listed on Shenzhen stock market in 2011, a national high-tech pharmaceutical company with headquarter in Zibo city, Shandong province.
The corporation is a fully integrated player with wide portfolios from starting raw materials, intermediates, APIs to FDFs and supplementary nutritional products in China, e.g. antibiotics, antivirals, gynecology, chronic diseases, pediatrics, hormones and immunomodulatory, liver diseases and other treatment fields, etc.

Total 10 manufacturing sites including： 

3 intermediates manufacturing sites (Cephalosporin side chains)

2 Chemcial API manufacturing sites (GMP factories, DMF & CEP is on going)

2 Biological API manufacturing sites (GMP factories, )

3 FDF manufacturing sites (GMP factories)

Annual Turnover of CNY 3.5+ Billion Yuan

Location
Q & A
1. Who we are ?
2. What we can supply?
3. Why Choose us?

Shandong Jincheng Pharmaceutical Group Co., Ltd. was established in 2004 and listed on Shenzhen stock market in 2011, a national high-tech pharmaceutical company with headquarter in Zibo city, Shandong province.

 

The corporation is a fully integrated player with wide portfolios from starting raw materials, intermediates, APIs to FDFs and supplementary nutritional products in China, e.g. antibiotics, antivirals,  gynecology, chronic diseases, pediatrics, hormones and immunomodulatory, liver diseases and other treatment fields, etc.

 

Total 10 manufacturing sites including： 

3 intermediates manufacturing sites (Cephalosporin side chains), 

2 Chemcial API manufacturing sites (GMP factories, DMF & CEP is on going)

2 Biological API manufacturing sites (GMP factories, )

3 FDF manufacturing sites (GMP factories)

Annual turnover of RMB 3.5+ billion yuan